Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 4 Feb 2015 |
| Major Shareholder Announcement | 4 Feb 2015 |
| Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma | 3 Feb 2015 |
| Genmab to Present at the 33rd Annual J.P. Morgan Healthcare Conference | 8 Jan 2015 |
| Articles of Association for Genmab A/S | 18 Dec 2014 |